Johnson & Johnson (NYSE:JNJ) saw a downside of -1.07% to $158.53 after subtracting -$1.72 on Tuesday. The 5-day average trading volume is 4,410,898 shares of the company’s common stock. It has gained $162.61 in the past week. An average of 6,278,450 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 5,749,508.
JNJ’s 1-month performance is -4.02% or -$8.35 on its low of $157.67 reached on 10/04/21. The company’s shares have touched a 52-week low of $133.65 and high of $179.92, with the stock’s rally to the 52-week high happening on 08/20/21. YTD, JNJ has achieved 1.82% or $1.24. However, the current price is down -11.89%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
On Dec 09, 307 days have gone by since the last insider trading activity for Johnson & Johnson (JNJ). Sneed Michael E (EVP, Global Corp Aff & COO) most recently sold 54,662 shares at $152.93 per share on Dec 09. This transaction cost the insider $8,359,460.
The company’s PE ratio for the last five years has touched a high of 379.85 and a low of 18.85. JNJ stock has a beta of 0.72. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.74 while the price-to-book (PB) in the most recent quarter is 6.15, with the price to cash flow ratio at 35.85.
Johnson & Johnson pays an annual dividend of $4.24 per share. Its dividend yield is 2.67% and the payout ratio is 60.90%. JNJ’s most recent quarterly dividend payment was made on Sep. 7, when it paid $1.06 a share compared with prior rate of $1.06, down 0.0% from last year’s. The company has boosted its dividend for the last 59 consecutive years with the latest dividend increase of $0.05 reported on Tuesday April 20 2021. Measured over the last 3 years, the Dividend has been growing by 19.88% yearly.
It is projected that Johnson & Johnson’s next ex-dividend date will be on 22-Nov-2021. JNJ is expected to distribute $1.06 as its next dividend.
Johnson & Johnson’s quick ratio for the period ended June 29 was 1.10, with the current ratio over the same period at 1.40 meaning that JNJ stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.44, while the total debt to equity was 0.48. In terms of profitability, the gross margin trailing 12 months is 67.10%. The trailing 12-month EBITDA margin is 33.55% while for the period ending June 29; Johnson & Johnson’s operating margin was 22.60%. The firm’s gross profit as reported stood at $54.16 billion against revenue of $82.58 billion.
For the quarterly period ending June 29 this year, Johnson & Johnson’s cash and short-term investments amounted to $10.97 billion against total debt of $33.48 billion. Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 21.35% to $23.31 billion, while revenue of $22.32 billion was 4.25% off the previous quarter. Analysts expected JNJ to announce $2.27 per share in earnings in its latest quarter, but it posted $2.48, representing a 9.30% surprise. EBITDA for the quarter stood at more than $8.55 billion. JNJ stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 106.86 billion, with total debt at $33.48 billion. Shareholders hold equity totaling $2.63 billion
Let’s look briefly at Johnson & Johnson (JNJ) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 27.46% to suggest the stock is trending oversold, with historical volatility in this time period at 10.61%.
The stock’s 5-day moving average is $160.21, reflecting a -0.60% or -$0.96 change from its current price. JNJ is currently trading -3.75% above its 20-day SMA, -7.28% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -7.92% and +4.03% respectively.
Stochastic %K and %D was 27.34% and 34.08% and the average true range (ATR) pointed at 2.20. The RSI (14) points at 29.18%, while the 14-day stochastic is at 11.69% with the period’s ATR at 2.20. The stock’s 9-day MACD Oscillator is pointing at -0.27 and -1.57 on the 14-day charts.
In the most recent analyst report for Johnson & Johnson (NYSE: JNJ), Morgan Stanley downgraded it to an Equal-weight rating. They previously had an Overweight rating on the stock. Analysts offering their rating for JNJ stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate JNJ as a “sell,”, while 7 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 3 rates the stock as overweight while 8 have offered a “buy” rating.
What is JNJ’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $158.00 and a high of $215.00, with their median price target at $188.05. Looking at these predictions, the average price target given by analysts is for Johnson & Johnson (JNJ) stock is $186.44.